These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 28638852)

  • 1. Olfactory dysfunction in patients with primary progressive MS.
    Schmidt FA; Maas MB; Geran R; Schmidt C; Kunte H; Ruprecht K; Paul F; Göktas Ö; Harms L
    Neurol Neuroimmunol Neuroinflamm; 2017 Jul; 4(4):e369. PubMed ID: 28638852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
    Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
    Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olfactory and Gustatory Dysfunction in Patients With Autoimmune Encephalitis.
    Geran R; Uecker FC; Prüss H; Haeusler KG; Paul F; Ruprecht K; Harms L; Schmidt FA
    Front Neurol; 2019; 10():480. PubMed ID: 31156532
    [No Abstract]   [Full Text] [Related]  

  • 4. Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis.
    Di Perri C; Battaglini M; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
    Arch Neurol; 2008 Feb; 65(2):236-43. PubMed ID: 18268194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olfactory dysfunction in multiple sclerosis: association with secondary progression.
    Silva AM; Santos E; Moreira I; Bettencourt A; Coutinho E; Gonçalves A; Pinto C; Montalban X; Cavaco S
    Mult Scler; 2012 May; 18(5):616-21. PubMed ID: 22020420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between olfactory bulb volume, cognitive dysfunction, physical disability and depression in multiple sclerosis.
    Yaldizli Ö; Penner IK; Yonekawa T; Naegelin Y; Kuhle J; Pardini M; Chard DT; Stippich C; Kira JI; Bendfeldt K; Amann M; Radue EW; Kappos L; Sprenger T
    Eur J Neurol; 2016 Mar; 23(3):510-9. PubMed ID: 26699999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical cord lesion load is associated with disability independently from atrophy in MS.
    Kearney H; Altmann DR; Samson RS; Yiannakas MC; Wheeler-Kingshott CA; Ciccarelli O; Miller DH
    Neurology; 2015 Jan; 84(4):367-73. PubMed ID: 25540312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomic Profiles for Primary Progressive Multiple Sclerosis Stratification and Disease Course Monitoring.
    Stoessel D; Stellmann JP; Willing A; Behrens B; Rosenkranz SC; Hodecker SC; Stürner KH; Reinhardt S; Fleischer S; Deuschle C; Maetzler W; Berg D; Heesen C; Walther D; Schauer N; Friese MA; Pless O
    Front Hum Neurosci; 2018; 12():226. PubMed ID: 29915533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-SPAG16 antibodies in primary progressive multiple sclerosis are associated with an elevated progression index.
    de Bock L; Fraussen J; Villar LM; Álvarez-Cermeño JC; Van Wijmeersch B; van Pesch V; Stinissen P; Somers V
    Eur J Neurol; 2016 Apr; 23(4):722-8. PubMed ID: 26706657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis.
    Malhotra S; Fissolo N; Tintoré M; Wing AC; Castilló J; Vidal-Jordana A; Montalban X; Comabella M
    J Neuroinflammation; 2015 Mar; 12():48. PubMed ID: 25879961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating microRNAs as biomarkers for disease staging in multiple sclerosis.
    Gandhi R; Healy B; Gholipour T; Egorova S; Musallam A; Hussain MS; Nejad P; Patel B; Hei H; Khoury S; Quintana F; Kivisakk P; Chitnis T; Weiner HL
    Ann Neurol; 2013 Jun; 73(6):729-40. PubMed ID: 23494648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olfactory threshold is impaired in early, active multiple sclerosis.
    Lutterotti A; Vedovello M; Reindl M; Ehling R; DiPauli F; Kuenz B; Gneiss C; Deisenhammer F; Berger T
    Mult Scler; 2011 Aug; 17(8):964-9. PubMed ID: 21372115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased plasma 8,12-iso-iPF2alpha- VI levels in relapsing multiple sclerosis patients are not predictive of disease progression.
    Teunissen CE; Sombekke M; van Winsen L; Killestein J; Barkhof F; Polman CH; Dijkstra CD; Blankenstein MA; Pratico D
    Mult Scler; 2012 Aug; 18(8):1092-8. PubMed ID: 22695538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.
    Kolind S; Seddigh A; Combes A; Russell-Schulz B; Tam R; Yogendrakumar V; Deoni S; Sibtain NA; Traboulsee A; Williams SC; Barker GJ; Brex PA
    Neuroimage Clin; 2015; 9():574-80. PubMed ID: 26594633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin in primary and secondary chronic progressive multiple sclerosis: a randomized placebo controlled multicentre study.
    Pöhlau D; Przuntek H; Sailer M; Bethke F; Koehler J; König N; Heesen C; Späth P; Andresen I
    Mult Scler; 2007 Nov; 13(9):1107-17. PubMed ID: 17623736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of results from olfactory testing.
    Gudziol V; Lötsch J; Hähner A; Zahnert T; Hummel T
    Laryngoscope; 2006 Oct; 116(10):1858-63. PubMed ID: 17003712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-Genome DNA Methylation Analysis of Peripheral Blood Mononuclear Cells in Multiple Sclerosis Patients with Different Disease Courses.
    Kulakova OG; Kabilov MR; Danilova LV; Popova EV; Baturina OA; Tsareva EY; Baulina NM; Kiselev IS; Boyko AN; Favorov AV; Favorova OO; Vlassov VV
    Acta Naturae; 2016; 8(3):103-110. PubMed ID: 27795849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain atrophy and physical disability in primary progressive multiple sclerosis: A volumetric study.
    Galego O; Gouveia A; Batista S; Moura C; Machado E
    Neuroradiol J; 2015 Jun; 28(3):354-8. PubMed ID: 26246109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics of primary progressive multiple sclerosis.
    Cree BA
    Handb Clin Neurol; 2014; 122():211-30. PubMed ID: 24507520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin generation correlates with disease duration in multiple sclerosis (MS): Novel insights into the MS-associated prothrombotic state.
    Parsons ME; O'Connell K; Allen S; Egan K; Szklanna PB; McGuigan C; Ní Áinle F; Maguire PB
    Mult Scler J Exp Transl Clin; 2017; 3(4):2055217317747624. PubMed ID: 29318029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.